Disparities in colorectal cancer in African-Americans vs Whites: Before and after diagnosis

World Journal of Gastroenterology

Volumn 15, Issue 30, 2009, Pages 3734-3743

  Dimou, Anastasios ^a   Syrigos, Kostas N ^a   Saif, Muhammad Wasif ^a  

^a YALE CANCER CENTER   (United States)

Author keywords

5 FU; African American; Caucasian; Chemotherapy; Colorectal cancer; Dihydropyrimidine dehydrogenase; Irinotecan; Oxaliplatin; Socioeconomic; Stage

Indexed keywords

ANTINEOPLASTIC AGENT; ARACHIDONATE LIPOXYGENASE; ASCORBIC ACID; BETA CAROTENE; BEVACIZUMAB; CALCIUM; FLUOROURACIL; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE T1; LACTULOSE;

ADJUVANT CHEMOTHERAPY; AFRICAN AMERICAN; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RISK; CANCER SCREENING; CANCER STAGING; CANCER SURVIVAL; CANCER SURVIVOR; CARCINOGENESIS; CAUCASIAN; COLONOSCOPY; COLORECTAL CANCER; DIAGNOSTIC ACCURACY; EDUCATIONAL STATUS; FEEDING BEHAVIOR; FOOD INTAKE; GENETIC POLYMORPHISM; HEALTH DISPARITY; HUMAN; INCOME; METASTASIS POTENTIAL; NEGRO; PROGNOSIS; QUALITY OF LIFE; RACE DIFFERENCE; REVIEW; RISK REDUCTION; SEX DIFFERENCE; SIGMOIDOSCOPY; SOCIOECONOMICS; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; COLORECTAL TUMOR; DRUG THERAPY; ETHNOLOGY; GENETIC PREDISPOSITION; GENETICS; MASS SCREENING; PSYCHOLOGICAL ASPECT; RADIOTHERAPY;

AFRICAN AMERICANS; COLORECTAL NEOPLASMS; DRUG THERAPY; EUROPEAN CONTINENTAL ANCESTRY GROUP; FOOD HABITS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MASS SCREENING; PROGNOSIS; QUALITY OF LIFE; RADIOTHERAPY;

EID: 70350446730     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.15.3734     Document Type: Review

References (107)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ. Cancer statistics, 2008. CA Cancer J Clin 2008; 58: 71-96
2. Zimmerman RK, Tabbarah M, Trauth J, Nowalk MP, Ricci EM. Predictors of lower endoscopy use among patients at three inner-city neighborhood health centers. J Urban Health 2006; 83: 221-230 (Pubitemid 44341574)
3. Etzioni DA, Yano EM, Rubenstein LV, Lee ML, Ko CY, Brook RH, Parkerton PH, Asch SM. Measuring the quality of colorectal cancer screening: the importance of follow-up. Dis Colon Rectum 2006; 49: 1002-1010 (Pubitemid 44060854)
4. Holmes-Rovner M, Williams GA, Hoppough S, Quillan L, Butler R, Given CW. Colorectal cancer screening barriers in persons with low income. Cancer Pract 2002; 10: 240-247 (Pubitemid 35034368)
5. Peterson NB, Murff HJ, Fowke JH, Cui Y, Hargreaves M, Signorello LB, Blot WJ. Use of colonoscopy and flexible sigmoidoscopy among African Americans and whites in a low-income population. Prev Chronic Dis 2008; 5: A28
6. Peterson NB, Murff HJ, Ness RM, Dittus RS. Colorectal cancer screening among men and women in the United States. J Womens Health (Larchmt) 2007; 16: 57-65 (Pubitemid 46302744)
7. James TM, Greiner KA, Ellerbeck EF, Feng C, Ahluwalia JS. Disparities in colorectal cancer screening: a guideline-based analysis of adherence. Ethn Dis 2006; 16: 228-233 (Pubitemid 46959272)
8. Vlahov D, Ahern J, Vazquez T, Johnson S, Philips LA, Nash D, Mitchell MK, Freeman H. Racial/ethnic differences in screening for colon cancer: report from the New York Cancer Project. Ethn Dis 2005; 15: 76-83 (Pubitemid 40310056)
9. Janz NK, Wren PA, Schottenfeld D, Guire KE. Colorectal cancer screening attitudes and behavior: a population-based study. Prev Med 2003; 37: 627-634 (Pubitemid 37443502)
10. Shokar NK, Carlson CA, Weller SC. Prevalence of colorectal cancer testing and screening in a multiethnic primary care population. J Community Health 2007; 32: 311-323 (Pubitemid 47497796)
11. Shokar NK, Carlson CA, Weller SC. Factors associated with racial/ethnic differences in colorectal cancer screening. J Am Board Fam Med 2008; 21: 414-426
12. Zhao BB, Kilbourne B, Stain SC, Van Cain A, Briggs NC, Husaini BA, Levine R. Racial disparities and trends in use of colorectal procedures among Tennessee elderly (1996-2000). Ethn Dis 2006; 16: 412-420
13. James AS, Campbell MK, Hudson MA. Perceived barriers and benefits to colon cancer screening among African Americans in North Carolina: how does perception relate to screening behavior? Cancer Epidemiol Biomarkers Prev 2002; 11: 529-534
14. Lawsin C, DuHamel K, Weiss A, Rakowski W, Jandorf L. Colorectal cancer screening among low-income African Americans in East Harlem: a theoretical approach to understanding barriers and promoters to screening. J Urban Health 2007; 84: 32-44 (Pubitemid 46147369)
15. Schroy PC 3rd, Glick JT, Robinson PA, Lydotes MA, Evans SR, Emmons KM. Has the surge in media attention increased public awareness about colorectal cancer and screening? J Community Health 2008; 33: 1-9
16. Palmer RC, Midgette LA, Dankwa I. Colorectal cancer screening and African Americans: findings from a qualitative study. Cancer Control 2008; 15: 72-79
17. Greiner KA, Born W, Nollen N, Ahluwalia JS. Knowledge and perceptions of colorectal cancer screening among urban African Americans. J Gen Intern Med 2005; 20: 977-983 (Pubitemid 41726649)
18. Katz ML, James AS, Pignone MP, Hudson MA, Jackson E, Oates V, Campbell MK. Colorectal cancer screening among African American church members: a qualitative and quantitative study of patient-provider communication. BMC Public Health 2004; 4: 62 (Pubitemid 44811707)
19. Taylor V, Lessler D, Mertens K, Tu SP, Hart A, Chan N, Shu J, Thompson B. Colorectal cancer screening among African Americans: the importance of physician recommendation. J Natl Med Assoc 2003; 95: 806-812 (Pubitemid 37139514)
20. Lipkus IM, Lyna PR, Rimer BK. Colorectal cancer risk perceptions and screening intentions in a minority population. J Natl Med Assoc 2000; 92: 492-500
21. Frank D, Swedmark J, Grubbs L. Colon cancer screening in African American women. ABNF J 2004; 15: 67-70
22. Coughlin SS, Thompson TD, Seeff L, Richards T, Stallings F. Breast, cervical, and colorectal carcinoma screening in a demographically defined region of the southern U.S. Cancer 2002; 95: 2211-2222 (Pubitemid 35253384)
23. O'Malley AS, Forrest CB, Feng S, Mandelblatt J. Disparities despite coverage: gaps in colorectal cancer screening among Medicare beneficiaries. Arch Intern Med 2005; 165: 2129-2135 (Pubitemid 41434589)
24. Shih YC, Zhao L, Elting LS. Does Medicare coverage of colonoscopy reduce racial/ethnic disparities in cancer screening among the elderly? Health Aff (Millwood) 2006; 25: 1153-1162 (Pubitemid 44188251)
25. Rajapaksa RC, Macari M, Bini EJ. Racial/ethnic differences in patient experiences with and preferences for computed tomography colonography and optical colonoscopy. Clin Gastroenterol Hepatol 2007; 5: 1306-1312 (Pubitemid 350019050)
26. McMahon LF Jr, Wolfe RA, Huang S, Tedeschi P, Manning W Jr, Edlund MJ. Racial and gender variation in use of diagnostic colonic procedures in the Michigan Medicare population. Med Care 1999; 37: 712-717
27. Murff HJ, Peterson NB, Fowke JH, Hargreaves M, Signorello LB, Dittus RS, Zheng W, Blot WJ. Colonoscopy screening in African Americans and Whites with affected first-degree relatives. Arch Intern Med 2008; 168: 625-631
28. Murff HJ, Peterson NB, Greevy RA, Shrubsole MJ, Zheng W. Early initiation of colorectal cancer screening in individuals with affected first-degree relatives. J Gen Intern Med 2007; 22: 121-126 (Pubitemid 47308791)
29. Griffith KA, McGuire DB, Royak-Schaler R, Plowden KO, Steinberger EK. Influence of family history and preventive health behaviors on colorectal cancer screening in African Americans. Cancer 2008; 113: 276-285
30. Rawl SM, Champion VL, Scott LL, Zhou H, Monahan P, Ding Y, Loehrer P, Skinner CS. A randomized trial of two print interventions to increase colon cancer screening among first-degree relatives. Patient Educ Couns 2008; 71: 215-227
31. Dolan NC, Ferreira MR, Fitzgibbon ML, Davis TC, Rademaker AW, Liu D, Lee J, Wolf M, Schmitt BP, Bennett CL. Colorectal cancer screening among African-American and white male veterans. Am J Prev Med 2005; 28: 479-482 (Pubitemid 40719050)
32. Kelly KM, Dickinson SL, Degraffinreid CR, Tatum CM, Paskett ED. Colorectal cancer screening in 3 racial groups. Am J Health Behav 2007; 31: 502-513
33. Schenck AP, Klabunde CN, Davis WW. Racial differences in colorectal cancer test use by Medicare consumers. Am J Prev Med 2006; 30: 320-326 (Pubitemid 43357921)
34. Fisher DA, Dougherty K, Martin C, Galanko J, Provenzale D, Sandler RS. Race and colorectal cancer screening: a population-based study in North Carolina. N C Med J 2004; 65: 12-15
35. Fisher DA, Jeffreys A, Coffman CJ, Fasanella K. Barriers to full colon evaluation for a positive fecal occult blood test. Cancer Epidemiol Biomarkers Prev 2006; 15: 1232-1235
36. McAlearney AS, Reeves KW, Dickinson SL, Kelly KM, Tatum C, Katz ML, Paskett ED. Racial differences in colorectal cancer screening practices and knowledge within a low-income population. Cancer 2008; 112: 391-398
37. Lieberman DA, Holub JL, Moravec MD, Eisen GM, Peters D, Morris CD. Prevalence of colon polyps detected by colonoscopy screening in asymptomatic black and white patients. JAMA 2008; 300: 1417-1422
38. Shavers VL. Racial/ethnic variation in the anatomic subsite location of in situ and invasive cancers of the colon. J Natl Med Assoc 2007; 99: 733-748
39. Thornton JG, Morris AM, Thornton JD, Flowers CR, McCashland TM. Racial variation in colorectal polyp and tumor location. J Natl Med Assoc 2007; 99: 723-728
40. Francois F, Park J, Bini EJ. Colon pathology detected after a positive screening flexible sigmoidoscopy: a prospective study in an ethnically diverse cohort. Am J Gastroenterol 2006; 101: 823-830
41. Cheng X, Chen VW, Steele B, Ruiz B, Fulton J, Liu L, Carozza SE, Greenlee R. Subsite-specific incidence rate and stage of disease in colorectal cancer by race, gender, and age group in the United States, 1992-1997. Cancer 2001; 92: 2547-2554
42. Irby K, Anderson WF, Henson DE, Devesa SS. Emerging and widening colorectal carcinoma disparities between Blacks and Whites in the United States (1975-2002). Cancer Epidemiol Biomarkers Prev 2006; 15: 792-797
43. Mostafa G, Matthews BD, Norton HJ, Kercher KW, Sing RF, Heniford BT. Influence of demographics on colorectal cancer. Am Surg 2004; 70: 259-264
44. Nelson RL, Dollear T, Freels S, Persky V. The relation of age, race, and gender to the subsite location of colorectal carcinoma. Cancer 1997; 80: 193-197 (Pubitemid 27282310)
45. Nelson RL, Persky V, Turyk M. Carcinoma in situ of the colorectum: SEER trends by race, gender, and total colorectal cancer. J Surg Oncol 1999; 71: 123-129 (Pubitemid 29288492)
46. Devesa SS, Chow WH. Variation in colorectal cancer incidence in the United States by subsite of origin. Cancer 1993; 71: 3819-3826
47. Matanoski G, Tao XG, Almon L, Adade AA, Davies-Cole JO. Demographics and tumor characteristics of colorectal cancers in the United States, 1998-2001. Cancer 2006; 107: 1112-1120
48. Shipp MP, Desmond R, Accortt N, Wilson RJ, Fouad M, Eloubeidi MA. Population-based study of the geographic variation in colon cancer incidence in Alabama: relationship to socioeconomic status indicators and physician density. South Med J 2005; 98: 1076-1082 (Pubitemid 41780346)
49. Haas JS, Earle CC, Orav JE, Brawarsky P, Neville BA, Williams DR. Racial segregation and disparities in cancer stage for seniors. J Gen Intern Med 2008; 23: 699-705
50. Cress RD, Morris C, Ellison GL, Goodman MT. Secular changes in colorectal cancer incidence by subsite, stage at diagnosis, and race/ethnicity, 1992-2001. Cancer 2006; 107: 1142-1152
51. Theuer CP, Taylor TH, Brewster WR, Anton-Culver H. Gender and race/ethnicity affect the cost-effectiveness of colorectal cancer screening. J Natl Med Assoc 2006; 98: 51-57 (Pubitemid 43076042)
52. Fairley TL, Cardinez CJ, Martin J, Alley L, Friedman C, Edwards B, Jamison P. Colorectal cancer in U.S. adults younger than 50 years of age, 1998-2001. Cancer 2006; 107: 1153-1161
53. Agrawal S, Bhupinderjit A, Bhutani MS, Boardman L, Nguyen C, Romero Y, Srinivasan R, Figueroa-Moseley C. Colorectal cancer in African Americans. Am J Gastroenterol 2005; 100: 515-523; discussion 514
54. Satia-Abouta J, Galanko JA, Martin CF, Potter JD, Ammerman A, Sandler RS. Associations of micronutrients with colon cancer risk in African Americans and whites: results from the North Carolina Colon Cancer Study. Cancer Epidemiol Biomarkers Prev 2003; 12: 747-754 (Pubitemid 36993165)
55. Sansbury LB, Millikan RC, Schroeder JC, Moorman PG, North KE, Sandler RS. Use of nonsteroidal antiinflammatory drugs and risk of colon cancer in a population-based, casecontrol study of African Americans and Whites. Am J Epidemiol 2005; 162: 548-558 (Pubitemid 41253253)
56. Satia-Abouta J, Galanko JA, Potter JD, Ammerman A, Martin CF, Sandler RS. Associations of total energy and macronutrients with colon cancer risk in African Americans and Whites: results from the North Carolina colon cancer study. Am J Epidemiol 2003; 158: 951-962 (Pubitemid 37413394)
57. O'Keefe SJ, Chung D, Mahmoud N, Sepulveda AR, Manafe M, Arch J, Adada H, van der Merwe T. Why do African Americans get more colon cancer than Native Africans? J Nutr 2007; 137: 175S-182S (Pubitemid 46070105)
58. Fulgoni V 3rd, Nicholls J, Reed A, Buckley R, Kafer K, Huth P, DiRienzo D, Miller GD. Dairy consumption and related nutrient intake in African-American adults and children in the United States: continuing survey of food intakes by individuals 1994-1996, 1998, and the National Health And Nutrition Examination Survey 1999-2000. J Am Diet Assoc 2007; 107: 256-264
59. Huang K, Sandler RS, Millikan RC, Schroeder JC, North KE, Hu J. GSTM1 and GSTT1 polymorphisms, cigarette smoking, and risk of colon cancer: a population-based case-control study in North Carolina (United States). Cancer Causes Control 2006; 17: 385-394
60. Slattery ML, Herrick J, Wolff RK, Caan BJ, Potter JD, Sweeney C. CDX2 VDR polymorphism and colorectal cancer. Cancer Epidemiol Biomarkers Prev 2007; 16: 2752-2755 (Pubitemid 351196332)
61. Keku T, Millikan R, Worley K, Winkel S, Eaton A, Biscocho L, Martin C, Sandler R. 5,10-Methylenetetrahydrofolate reductase codon 677 and 1298 polymorphisms and colon cancer in African Americans and whites. Cancer Epidemiol Biomarkers Prev 2002; 11: 1611-1621 (Pubitemid 36020015)
62. Goodman JE, Bowman ED, Chanock SJ, Alberg AJ, Harris CC. Arachidonate lipoxygenase (ALOX) and cyclooxygenase (COX) polymorphisms and colon cancer risk. Carcinogenesis 2004; 25: 2467-2472
63. Peters U, McGlynn KA, Chatterjee N, Gunter E, Garcia-Closas M, Rothman N, Sinha R. Vitamin D, calcium, and vitamin D receptor polymorphism in colorectal adenomas. Cancer Epidemiol Biomarkers Prev 2001; 10: 1267-1274 (Pubitemid 34027758)
64. Butler LM, Millikan RC, Sinha R, Keku TO, Winkel S, Harlan B, Eaton A, Gammon MD, Sandler RS. Modification by N-acetyltransferase 1 genotype on the association between dietary heterocyclic amines and colon cancer in a multiethnic study. Mutat Res 2008; 638: 162-174
65. Koshiji M, Kumamoto K, Morimura K, Utsumi Y, Aizawa M, Hoshino M, Ohki S, Takenoshita S, Costa M, Commes T, Piquemal D, Harris CC, Tchou-Wong KM. Correlation of N-myc downstream-regulated gene 1 expression with clinical outcomes of colorectal cancer patients of different race/ethnicity. World J Gastroenterol 2007; 13: 2803-2810 (Pubitemid 47007894)
66. Piffath TA, Whiteman MK, Flaws JA, Fix AD, Busht TL. Ethnic differences in cancer mortality trends in the US, 1950-1992. Ethn Health 2001; 6: 105-119
67. Recent trends in mortality rates for four major cancers, by sex and race/ethnicity - United States, 1990-1998. MMWR Morb Mortal Wkly Rep 2002; 51: 49-53
68. Rabeneck L, Souchek J, El-Serag HB. Survival of colorectal cancer patients hospitalized in the Veterans Affairs Health Care System. Am J Gastroenterol 2003; 98: 1186-1192 (Pubitemid 36733786)
69. Bach PB, Schrag D, Brawley OW, Galaznik A, Yakren S, Begg CB. Survival of blacks and whites after a cancer diagnosis. JAMA 2002; 287: 2106-2113 (Pubitemid 34437345)
70. Dignam JJ, Ye Y, Colangelo L, Smith R, Mamounas EP, Wieand HS, Wolmark N. Prognosis after rectal cancer in blacks and whites participating in adjuvant therapy randomized trials. J Clin Oncol 2003; 21: 413-420 (Pubitemid 46606468)
71. Du XL, Fang S, Vernon SW, El-Serag H, Shih YT, Davila J, Rasmus ML. Racial disparities and socioeconomic status in association with survival in a large population-based cohort of elderly patients with colon cancer. Cancer 2007; 110: 660-669
72. Mayberry RM, Coates RJ, Hill HA, Click LA, Chen VW, Austin DF, Redmond CK, Fenoglio-Preiser CM, Hunter CP, Haynes MA. Determinants of black/white differences in colon cancer survival. J Natl Cancer Inst 1995; 87: 1686-1693
73. Gomez SL, O'Malley CD, Stroup A, Shema SJ, Satariano WA. Longitudinal, population-based study of racial/ethnic differences in colorectal cancer survival: impact of neighborhood socioeconomic status, treatment and comorbidity. BMC Cancer 2007; 7: 193 (Pubitemid 351234157)
74. Du XL, Meyer TE, Franzini L. Meta-analysis of racial disparities in survival in association with socioeconomic status among men and women with colon cancer. Cancer 2007; 109: 2161-2170 (Pubitemid 46801545)
75. Marcella S, Miller JE. Racial differences in colorectal cancer mortality. The importance of stage and socioeconomic status. J Clin Epidemiol 2001; 54: 359-366 (Pubitemid 32303459)
76. Chien C, Morimoto LM, Tom J, Li CI. Differences in colorectal carcinoma stage and survival by race and ethnicity. Cancer 2005; 104: 629-639 (Pubitemid 41022822)
77. Le H, Ziogas A, Lipkin SM, Zell JA. Effects of socioeconomic status and treatment disparities in colorectal cancer survival. Cancer Epidemiol Biomarkers Prev 2008; 17: 1950-1962
78. Kinsey T, Jemal A, Liff J, Ward E, Thun M. Secular trends in mortality from common cancers in the United States by educational attainment, 1993-2001. J Natl Cancer Inst 2008; 100: 1003-1012
79. Alexander D, Chat la C, Funkhouser E, Meleth S, Grizzle WE, Manne U. Postsurgical disparity in survival between African Americans and Caucasians with colonic adenocarcinoma. Cancer 2004; 101: 66-76 (Pubitemid 38812424)
80. Alexander D, Jhala N, Chatla C, Steinhauer J, Funkhouser E, Coffey CS, Grizzle WE, Manne U. High-grade tumor differentiation is an indicator of poor prognosis in African Americans with colonic adenocarcinomas. Cancer 2005; 103: 2163-2170 (Pubitemid 40605125)
81. Wudel LJ Jr, Chapman WC, Shyr Y, Davidson M, Jeyakumar A, Rogers SO Jr, Allos T, Stain SC. Disparate outcomes in patients with colorectal cancer: effect of race on long-term survival. Arch Surg 2002; 137: 550-554; discussion 554-556
82. Ayanian JZ, Zaslavsky AM, Guadagnoli E, Fuchs CS, Yost KJ, Creech CM, Cress RD, O'Connor LC, West DW, Wright WE. Patients' perceptions of quality of care for colorectal cancer by race, ethnicity, and language. J Clin Oncol 2005; 23: 6576-6586 (Pubitemid 46190251)
83. Morris AM, Billingsley KG, Baxter NN, Baldwin LM. Racial disparities in rectal cancer treatment: a population-based analysis. Arch Surg 2004; 139: 151-155; discussion 156
84. Doubeni CA, Field TS, Buist DS, Korner EJ, Bigelow C, Lamerato L, Herrinton L, Quinn VP, Hart G, Hornbrook MC, Gurwitz JH, Wagner EH. Racial differences in tumor stage and survival for colorectal cancer in an insured population. Cancer 2007; 109: 612-620 (Pubitemid 46190971)
85. Demissie K, Oluwole OO, Balasubramanian BA, Osinubi OO, August D, Rhoads GG. Racial differences in the treatment of colorectal cancer: a comparison of surgical and radiation therapy between Whites and Blacks. Ann Epidemiol 2004; 14: 215-221 (Pubitemid 38249336)
86. Rogers SO, Ray WA, Smalley WE. A population-based study of survival among elderly persons diagnosed with colorectal cancer: does race matter if all are insured? (United States). Cancer Causes Control 2004; 15: 193-199
87. Morris AM, Wei Y, Birkmeyer NJ, Birkmeyer JD. Racial disparities in late survival after rectal cancer surgery. J Am Coll Surg 2006; 203: 787-794 (Pubitemid 44751552)
88. Govindarajan R, Shah RV, Erkman LG, Hutchins LF. Racial differences in the outcome of patients with colorectal carcinoma. Cancer 2003; 97: 493-498 (Pubitemid 36133817)
89. Jessup JM, Stewart A, Greene FL, Minsky BD. Adjuvant chemotherapy for stage III colon cancer: implications of race/ethnicity, age, and differentiation. JAMA 2005; 294: 2703-2711 (Pubitemid 41770099)
90. Morris AM, Billingsley KG, Hayanga AJ, Matthews B, Baldwin LM, Birkmeyer JD. Residual treatment disparities after oncology referral for rectal cancer. J Natl Cancer Inst 2008; 100: 738-744
91. Baldwin LM, Dobie SA, Billingsley K, Cai Y, Wright GE, Dominitz JA, Barlow W, Warren JL, Taplin SH. Explaining black-white differences in receipt of recommended colon cancer treatment. J Natl Cancer Inst 2005; 97: 1211-1220 (Pubitemid 41258227)
92. Potosky AL, Harlan LC, Kaplan RS, Johnson KA, Lynch CF. Age, sex, and racial differences in the use of standard adjuvant therapy for colorectal cancer. J Clin Oncol 2002; 20: 1192-1202
93. Dobie SA, Baldwin LM, Dominitz JA, Matthews B, Billingsley K, Barlow W. Completion of therapy by Medicare patients with stage III colon cancer. J Natl Cancer Inst 2006; 98: 610-619 (Pubitemid 43904844)
94. McGory ML, Zingmond DS, Sekeris E, Bastani R, Ko CY. A patient's race/ethnicity does not explain the underuse of appropriate adjuvant therapy in colorectal cancer. Dis Colon Rectum 2006; 49: 319-329
95. Goldberg RM, McLeod HL, Sargent DJ Morton RF, Green EM, Fuchs C, Ramanathan RK, Williamson SK, Findley BP, Pitot HC, Alberts SR. Genetic polymorphisms, toxicity, and response rate in African Americans (AA) with metastatic colorectal cancer (MCRC) compared to Caucasians (C) when treated with IFL, FOLFOX or IROX in Intergroup N9741. 2006 ASCO Annual Meeting Abstract No. 3503
96. McLeod HL, Parodi L, Sargent J, Marsh S, Green E, Abreu P, Cisar LA, Goldberg RM. UGT1A1*28 toxicity and outcome in advanced colorectal cancer: Results from trial N9741. 2006 ASCO Annual Meeting Abstract No. 3520
97. Catalano PJ, Mitchell EP, Giantonio BJ, Meropol NJ, Benson AB. Outcomes of African Americans and Caucasians treated with bevacizumab, FOLFOX4 or the combination in patients with metastatic colorectal cancer (MCRC): Results from the Eastern Coooperative Oncology Group Study E3200. 2007 ASCO Annual Meeting Abstract No. 4100
98. McCollum AD, Catalano PJ, Haller DG, Mayer RJ, Macdonald JS, Benson AB 3rd, Fuchs CS. Outcomes and toxicity in african-american and caucasian patients in a randomized adjuvant chemotherapy trial for colon cancer. J Natl Cancer Inst 2002; 94: 1160-1167
99. Mattison LK, Fourie J, Desmond RA, Modak A, Saif MW, Diasio RB. Increased prevalence of dihydropyrimidine dehydrogenase deficiency in African-Americans compared with Caucasians. Clin Cancer Res 2006; 12: 5491-5495 (Pubitemid 44497265)
100. Waqar SN, Tan BR, Zubal B, Kuperman DI, Adkins DR. Race and albuterol premedication are risk factors for hypersensitivity reactions to cetuximab. 2008 ASCO Annual Meeting Abstract No. 20503
101. Chen VW, Fenoglio-Preiser CM, Wu XC, Coates RJ, Reynolds P, Wickerham DL, Andrews P, Hunter C, Stemmermann G, Jackson JS, Edwards BK. Aggressiveness of colon carcinoma in blacks and whites. National Cancer Institute Black/White Cancer Survival Study Group. Cancer Epidemiol Biomarkers Prev 1997; 6: 1087-1093
102. Ahuja N, Chang D, Gearhart SL. Disparities in colon cancer presentation and in-hospital mortality in Maryland: a ten-year review. Ann Surg Oncol 2007; 14: 411-416 (Pubitemid 46175283)
103. Phipps E, Braitman LE, Stites S, Leighton JC. Quality of life and symptom attribution in long-term colon cancer survivors. J Eval Clin Pract 2008; 14: 254-258 (Pubitemid 351347700)
104. Satia JA, Campbell MK, Galanko JA, James A, Carr C, Sandler RS. Longitudinal changes in lifestyle behaviors and health status in colon cancer survivors. Cancer Epidemiol Biomarkers Prev 2004; 13: 1022-1031 (Pubitemid 38756713)
105. Rolnick S, Hensley Alford S, Kucera GP, Fortman K, Ulcickas Yood M, Jankowski M, Johnson CC. Racial and age differences in colon examination surveillance following a diagnosis of colorectal cancer. J Natl Cancer Inst Monogr 2005; 96-101
106. Ellison GL, Warren JL, Knopf KB, Brown ML. Racial differences in the receipt of bowel surveillance following potentially curative colorectal cancer surgery. Health Serv Res 2003; 38: 1885-1903
107. Rulyak SJ, Mandelson MT, Brentnall TA, Rutter CM, Wagner EH. Clinical and sociodemographic factors associated with colon surveillance among patients with a history of colorectal cancer. Gastrointest Endosc 2004; 59: 239-247